Blog

Glutathione supports immune function by sustaining T-cell proliferation and NK cell activity — clinical trials show 500–1000mg daily improves lymphocyte

Epithalon anti-aging protocol dosage timing depends on circadian alignment and peptide half-life. Learn 10-day cycles, injection timing, and storage

VIP (Vasoactive Intestinal Peptide) modulates T-cell function and cytokine regulation through direct immune pathway interaction. Research shows promise

NAD+ depletion accelerates aging markers in controlled trials. Mouse models show 20-40% lifespan extension, but human translation remains contested with

FOXO4-DRI targets senescent cells by disrupting p53-FOXO4 binding, enabling cellular apoptosis. Evidence shows promise in pre-clinical models — but human

FOXO4-DRI anti-aging protocol dosage timing requires precise subcutaneous administration every 3–4 days at 5mg doses to maintain therapeutic plasma levels

GHK-Cu’s half-life of 30 minutes dictates precise dosing timing. Split 200–300µg daily doses or time single injections around sleep for peak collagen

GHK-Cu demonstrates measurable collagen synthesis, wound healing acceleration, and anti-inflammatory effects in controlled trials — here’s what the

NAD+ supplements work best when timed with your circadian rhythm — morning dosing supports mitochondrial function while evening doses may disrupt sleep

Thymalin anti-aging protocol dosage timing spans 10–20 days at 5–10mg daily, with twice-weekly maintenance after. Timing, reconstitution, and cycle

Sermorelin anti-aging protocol dosage timing requires 200–500 mcg subcutaneously before sleep for optimal GH pulse synchronization — learn precise

Sermorelin stimulates endogenous growth hormone release via pituitary GHRH receptors. Clinical trials show improved body composition, sleep quality, and

CJC-1295 stimulates sustained growth hormone release, showing 200–300% plasma GH increases in clinical trials — evidence for anti-aging includes collagen

Thymalin demonstrates immune restoration in clinical trials with 30–40% T-cell recovery in immunosenescent adults. Research-backed mechanisms, dosing

MOTS-c shows mitochondrial repair potential in aging research, with rodent trials demonstrating metabolic and longevity effects worth examining closely.

SS-31 shows cellular energy restoration in anti-aging research. Mitochondrial trials demonstrate ATP recovery, oxidative stress reduction, and tissue

SS-31 anti-aging protocol dosage timing requires twice-daily subcutaneous administration spaced 8–12 hours apart to maintain plasma mitochondrial membrane

Ipamorelin anti-aging protocol dosage timing requires 200-300mcg doses administered 2-3 times daily on an empty stomach — dosing precision determines GH

Ipamorelin stimulates growth hormone release without cortisol or prolactin spikes. Clinical trials show improved lean mass retention and recovery markers

CJC-1295 anti-aging protocol dosage timing requires subcutaneous administration 1–3× weekly before sleep to align with natural GH pulse secretion for

Cartalax works best when injected 30–60 minutes before sleep — the peptide aligns with the body’s natural repair window when growth hormone and cellular

Cartalax demonstrates telomere protection and mitochondrial optimization in cellular aging models. We break down the published evidence and real study

Using Pinealon for anti-aging research evidence reveals neuroprotective effects in animal models and observational human trials, though FDA-approved

PT-141 requires precise dosing 45–60 minutes pre-activity for peak melanocortin receptor activation — timing errors negate efficacy entirely.

Melanotan-2 demonstrated significant erectile function improvement in double-blind trials, with mechanisms extending beyond melanocortin pathways to

Melanotan-2’s sexual benefits emerge 2–6 hours post-injection at 0.5–1.5mg doses. Timing, stacking protocols, and receptor mechanisms determine efficacy

Kisspeptin regulates reproductive hormones and sexual arousal through direct hypothalamic signaling — backed by Phase 2 trials showing measurable effects

MOTS-c anti-aging protocol dosage timing centers on 5–10mg subcutaneous injections 2–3 times weekly, administered in morning fasted states for

Oxytocin sexual health protocol dosage timing requires 20–40 IU intranasal administration 15–30 minutes before intimacy for peak receptor activation.

Oxytocin modulates sexual arousal, bonding, and orgasmic response through CNS pathways — clinical trials show dose-dependent effects on intimacy behaviors.

Kisspeptin sexual health protocol dosage timing requires 1–10mg subcutaneous administration 30–60 minutes pre-activity for peak GnRH pulsatility and LH

Pinealon anti-aging protocol dosage timing depends on circadian neuroendocrine peaks — 10mg subcutaneous before bed optimizes pineal receptor density

Selank demonstrates anxiolytic effects through GABA modulation and BDNF upregulation in animal models, though human clinical data remains limited to small

Selank’s five-day half-life requires specific timing protocols to maintain anxiolytic effects without tolerance development — here’s the evidence-based

PT-141 (bremelanotide) shows measurable improvements in sexual desire disorders via melanocortin receptor pathways — clinical evidence includes

DSIP anxiety protocol dosage timing centers on 1-3mg subcutaneous injections administered 30-60 minutes before bed to leverage delta sleep-inducing

DSIP shows anxiolytic effects in animal models via GABA modulation and HPA axis regulation, though human trial data remains limited to small cohorts.

PE-22-28 anxiety protocol requires 100–300 mcg per dose, administered subcutaneously every 3–7 days depending on individual response and research design.

Oxytocin modulates amygdala activity and cortisol response in anxiety research. Clinical trials show mixed results — here’s what the evidence actually

Research on using Semax Amidate for anxiety shows promising anxiolytic effects through BDNF upregulation and HPA axis modulation — here’s what the

Oxytocin anxiety protocol dosage timing requires 10–40 IU intranasal doses before stress triggers, with receptor sensitization peaking at 45–90 minutes

Pe-22-28 shows GABAergic anxiolytic effects in preclinical models through allosteric GABA-A receptor modulation without benzodiazepine-like sedation or

Semax Amidate’s anxiolytic effects require precise dosage timing — 300–600mcg intranasal, split-dose morning and early afternoon delivers optimal BDNF

TB-500 accelerates wound healing through beta-actin upregulation — dosage timing, injection frequency, and reconstitution protocols determine clinical

BPC-157 accelerates tissue repair through upregulated VEGF and fibroblast activity. Discover the exact dosing windows, subcutaneous vs. oral timing, and

TB-500 accelerates wound healing in animal models by upregulating angiogenesis and collagen deposition. Here’s what current research reveals.

BPC-157 accelerates wound healing through angiogenesis and collagen synthesis — rodent studies show 60–80% faster closure, but human trials remain absent.

GHK-Cu accelerates wound closure by 30-40% in controlled studies through collagen synthesis and angiogenesis — here’s what the research shows about this

KPV demonstrates selective anti-inflammatory action through melanocortin receptor pathways, showing wound closure acceleration in preclinical models.

TB-4 wound healing protocol dosage timing requires 2–10mg injections twice weekly for acute injuries or 5mg weekly for chronic tissue repair based on

LL-37 accelerates wound closure through antimicrobial activity and immune modulation. Research shows 40–60% faster epithelialization in animal models.

TB-4 accelerates wound healing by promoting angiogenesis and cell migration in preclinical models — here’s what the clinical evidence actually shows and

KPV requires 200–500mcg subcutaneous injection twice daily, 12 hours apart, for 4–6 weeks to achieve anti-inflammatory wound healing effects through MSH

LL-37 wound healing protocol dosage timing requires subcutaneous injection 1–2 times daily at 200–500mcg per dose for 4–8 weeks to optimize antimicrobial

Wolverine Stack combines BPC-157, TB-500, and GHK-Cu — research shows accelerated collagen synthesis, reduced inflammation, and faster tissue repair.

KLOW (KPV tripeptide) shows anti-inflammatory wound healing effects via NF-κB inhibition. Clinical evidence, mechanisms, protocols, and study design

The Wolverine Stack combines BPC-157, TB-500, and GHK-Cu using synergistic dosing and split-window timing to accelerate tissue repair by 40–60% over

KLOW wound healing protocol dosage timing depends on injury phase — inflammatory stage requires 200mcg BID while proliferative needs 100mcg daily for

GHK-Cu wound healing protocol dosage timing requires 1–2mg daily, split morning/evening for 12+ weeks. Bioavailability peaks 2–4 hours post-injection.

KPV peptide demonstrates anti-inflammatory effects through α-MSH pathway modulation—published trials show significant cytokine reduction without